Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Hot Flashes 6Breast Neoplasms 6Pain, Postoperative 3Head and Neck Neoplasms 3Vomiting 2Prostatic Neoplasms 2Pain 2Nausea 2Mucositis 2Depression 2Anxiety Disorders 2Acute Pain 2Urinary Bladder Neoplasms 1Stomatitis 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Squamous Cell Carcinoma of Head and Neck 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neuralgia 1Neoplasms 1Laryngeal Diseases 1Agnosia 1Abnormalities, Radiation-Induced 1

Interventions

oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Pain Management 1Methods 1Ibuprofen 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Abnormalities, Radiation-Induced × Gabapentin × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡